Product image of Kainever (Estazolam) supplied by GNH India

Kainever

Active Ingredient:
Estazolam
Origin:
EU

Kainever (Estazolam)

Estazolam, the active ingredient in Kainever, is a benzodiazepine presented as an oral tablet for oral use. It is used to manage insomnia and anxiety disorders in adult patients.

GNH India supplies Kainever as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratório Medinfar - Produtos Farmacêuticos, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Estazolam is indicated for conditions involving the central nervous system where sedation or anxiolysis is required.

  • Insomnia: helps initiate and maintain sleep, improving overall sleep quality.
  • Anxiety disorders: reduces excessive worry and tension, providing symptomatic relief.
  • Pre‑operative anxiety: offers short‑term calming effect before medical procedures.

How It Works

  • Estazolam acts as a positive allosteric modulator at the GABA‑A receptor complex. By binding to the benzodiazepine site, it enhances the affinity of the receptor for the inhibitory neurotransmitter GABA, increasing chloride ion influx and hyperpolarizing neuronal membranes. This potentiation of GABAergic transmission leads to decreased neuronal excitability, producing sedative, hypnotic, anxiolytic, and muscle‑relaxant effects.

Side Effects

Estazolam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Drowsiness: feeling of sleepiness during daytime.
  • Dizziness: sensation of light‑headedness or imbalance.
  • Impaired coordination: reduced motor control and steadiness.
  • Memory disturbances: difficulty recalling recent events.
  • Headache: mild to moderate cranial pain.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing, especially with high doses.
  • Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Paradoxical aggression: unexpected agitation or hostility.
  • Dependence or withdrawal: physical or psychological reliance after prolonged use.
  • Mood changes: depression or suicidal thoughts.

Precautions & Warnings

When prescribing Estazolam, clinicians should consider several safety precautions to minimize risks.

  • Assess patient history: evaluate prior benzodiazepine use, substance abuse, or psychiatric conditions.
  • Use lowest effective dose: start with the minimal dose needed for therapeutic effect.
  • Limit duration: restrict use to short‑term periods to avoid dependence.
  • Avoid abrupt discontinuation: taper gradually under medical supervision.
  • Caution in elderly: increased sensitivity to sedation and fall risk.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Estazolam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Opioids: combined use may cause profound respiratory depression.
  • CNS depressants: alcohol, barbiturates, or antihistamines increase sedation risk.
  • Antifungal agents (e.g., ketoconazole): may raise estazolam plasma levels.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs, SNRIs): may enhance central nervous system effects.
  • Anticonvulsants (e.g., carbamazepine): may reduce estazolam concentrations.
  • CYP3A4 inhibitors (e.g., erythromycin): can modestly increase drug exposure.

Frequently Asked Questions

Kainever contains the benzodiazepine estazolam and is prescribed to treat insomnia and various anxiety disorders in adult patients. It works by promoting sedation and reducing excessive nervous tension, helping patients achieve better sleep quality and calmer mental states under medical supervision.

Estazolam binds to the benzodiazepine site on the GABA‑A receptor complex, enhancing the effect of the inhibitory neurotransmitter GABA. This increases chloride ion flow into neurons, leading to hyperpolarization and reduced neuronal excitability, which produces sedative, hypnotic, and anxiolytic effects.

The appropriate dose of Kainever is determined by the prescribing clinician based on the individual’s medical condition, age, response to therapy, and other medications. Dosage adjustments are made to achieve the desired therapeutic effect while minimizing adverse reactions.

The safety of estazolam in pregnancy and lactation has not been definitively established. Healthcare providers generally weigh the potential benefits against possible risks to the fetus or infant, and alternative treatments may be considered when appropriate.

To request Kainever, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other benzodiazepines, estazolam has a relatively intermediate half‑life and is often selected for short‑term management of insomnia and anxiety. Its pharmacokinetic profile may offer a balance between rapid onset and reduced next‑day sedation relative to longer‑acting agents.

Kainever should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Kainever is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed, unless otherwise directed by a healthcare professional. Dosing times are typically aligned with bedtime for insomnia or as prescribed for anxiety.

The most serious risks include respiratory depression, especially when combined with other central nervous system depressants, severe allergic reactions, and the potential for dependence, tolerance, or withdrawal symptoms after prolonged use. Patients should be monitored closely for these events.

Kainever is contraindicated in individuals with known hypersensitivity to estazolam or other benzodiazepines, those with severe respiratory insufficiency, acute narrow‑angle glaucoma, and patients with a history of substance misuse who cannot be reliably monitored. Use in the elderly requires special caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.